covid -19

The Ministry of Health and Family Welfare reported 12,249 new COVID-19 cases in India in the previous 24 hours.

Active cases currently account for 0.19 percent of all positive cases in the country. The number of active cases in the country is presently 81,687, with a daily positive rate of 3.94 percent.

According to the Ministry bulletin, up to 13 persons perished from the illness in the previous 24 hours.

A total of 9,862 patients recovered from COVID, bringing the recovery rate to 98.60%.

The total number of COVID recoveries is currently 4,27,25,055.

In the previous 24 hours, 3,10,623 COVID-19 tests were performed. India has performed around 85.88 Cr (85,88,36,977) cumulative tests to date.

The cumulative COVID-19 vaccination coverage in India reaches 196.45 crore, with 1,96,45,99,906 persons vaccinated.

Also Read: WHO approved Biological E Limited as additional production location for Johnson & Johnson’s COVID-19 vaccine

Covid vaccines

COVID-19 vaccination for children aged 12 to 14 years old began on March 16, 2022. So far, the first dose of the COVID-19 vaccine has been provided to 3,58,99,199 adolescents.

As part of the statewide vaccination campaign, the Government of India has been supplying free COVID vaccines to states and union territories. In the next phase of the COVID19 vaccination programme, the Union Government would acquire and deliver (at no cost) to States and UTs 75% of the vaccines manufactured in the country by vaccine makers.

So date, more than 193.53 crore (1,93,53,58,865) vaccine doses have been distributed to states/UTs through the Government of India (free of cost channel) and the direct state purchase category.

More than 12.53 Cr (12,53,04,250) of balance and unutilized COVID Vaccine doses are still available for administration with the States/UTs.

In light of the recent increase in COVID-19 instances recorded throughout the country, the Health Ministry of India asked states and union territories on June 9 to be vigilant and rigorously adhere to COVID-appropriate behaviour.

Union Health Secretary Rajesh Bhushan asked States/UTs on Thursday to increase RT-PCR testing, monitoring, clinical management, vaccination, COVID-19 procedures, and adopt prompt preventive measures in a letter. Bhushan also encouraged the administration to use a “five-fold” strategy.

Follow Medically Speaking on Instagram

Women are “significantly” more likely than men to suffer from extended Covid and will have dramatically different symptoms, according to a study, highlighting the crucial need for gender-disaggregated studies. Long Covid is a condition in which problems continue for more than four weeks after the initial Covid-19 infection, and occasionally for months.

Also Read: Covid virus most likely leaked from Wuhan laboratory: WHO Director-General

Researchers from the Johnson & Johnson Office of the Chief Medical Officer Health of Women Team observed females with long Covid presenting with a variety of symptoms including ear, nose, and throat issues, mood disorders, neurological, skin, gastrointestinal, and rheumatological disorders, as well as fatigue.

Male patients, on the other hand, were more prone to develop endocrine illnesses such as diabetes and renal disease. Females had a 22% greater chance of having extended Covid syndrome than males, according to the study published in the journal Current Medical Research and Opinion.

“Knowledge about fundamental sex differences underlying Covid-19 clinical manifestations, disease progression, and health outcomes is critical for the identification and rational design of effective therapies and public health interventions that are inclusive of and sensitive to the potential differential treatment needs of both sexes,” the researchers wrote.

“Variations in immune system function between males and females may be a major cause of sex differences in extended Covid syndrome.” Females have more quick and strong innate and adaptive immune responses, which can shield them from the severity of the initial illness.

This similar difference, however, can make females more prone to long-term autoimmune-related disorders,” they noted. The researchers evaluated 640,634 total papers for the study, totaling 1,393,355 distinct people.

Notably, women may be more vulnerable to the virus in specific occupations, such as nursing and teaching, according to the study. Furthermore, “gender differences in access to care may influence the natural course of the disease, leading to increased problems and sequela.”

Follow Medically Speaking on Instagram

With 9,923 new instances of Coronavirus infection and 17 deaths owing to Covid-19 in the country, India has observed a small decrease in infections in the previous 24 hours.

On Monday, India reported 12,781 new COVID-19 cases and 18 fatalities. According to India’s Ministry of Health and Family Welfare, 7,293 people recovered at a rate of 98.61 percent in the previous 24 hours, bringing the total number of people recovered from the virus to 4,27,15,193.

Notably, the total number of active cases in the country is 79,313 at a rate of 0.18 percent and a current positive rate of 2.55%.

India has done 85.85 crore tests in total, with 3,88,641 conducted in the previous 24 hours.

According to data, the country’s weekly positive rate is 2.67 percent.

Covid vaccines

According to the ministry, 196.32 crore vaccine doses have been provided to states/union territories as part of the Government of India’s Nationwide Vaccination Drive (free of cost channel).

The Central Government is dedicated to speeding up and broadening the scope of COVID-19 vaccination across the country. The national COVID-19 vaccine campaign began on January 16, 2021.

The next phase of COVID-19 vaccine universalization began on June 21, 2021. The immunisation campaign has been stepped up with the availability of more vaccinations, increased visibility of vaccine availability to states and UTs for better planning, and simplification of the vaccine supply chain.

Also Read: Cases increasing as people not following COVID-19 guidelines: Health expert

As part of the countrywide vaccination campaign, the Government of India has been supplying free COVID-19 vaccinations to states and union territories. In the next phase of the COVID-19 vaccination programme, the Union Government would acquire and deliver (at no cost) to States and UTs 75% of the vaccines manufactured in the country by vaccine makers.

In light of the recent increase in COVID-19 instances recorded throughout the country, the Health Ministry of India asked states and union territories on June 9 to be vigilant and rigorously adhere to COVID-appropriate behaviour. Union Health Secretary Rajesh Bhushan asked States/UTs on Thursday to increase RT-PCR testing, monitoring, clinical management, vaccination, COVID-19 procedures, and adopt prompt preventive measures in a letter. Bhushan also asked the government to use a “five-pronged Strategy.”

Follow Medically Speaking on Instagram

The use of novel fusion proteins in simple and accurate glucose meter-based testing has been described by researchers. They believe that one day, people will be able to use this assay to monitor their SARS-CoV-2 antibody levels.

The findings were reported in the American Chemical Society Journal (ACS). Vaccines against SARS-CoV-2 and infection with the virus can protect against subsequent infections for a while, but how long that protection lasts is unknown. A person’s level of SARS-CoV-2 antibodies is an excellent indicator of immunological protection, but the gold standard test – the enzyme-linked immunosorbent assay (ELISA) – is costly and needs skilled personnel.

Introducing glucose metres, which are widely available, simple to use, and may be linked to remote healthcare services. Researchers have been modifying these devices to detect different target chemicals while also producing glucose.

If a detecting antibody in the test attaches to an antibody in a patient’s blood, a reaction happens that creates glucose, which the instrument detects extremely effectively. Invertase is an appealing enzyme for this sort of research since it transforms sucrose to glucose, but chemical methods make attaching the enzyme to detecting antibodies problematic.

So Netzahualcoyotl Arroyo-Curras, Jamie B. Spangler, and colleagues wanted to explore if creating a fusion protein containing both invertase and a detection antibody would work in an experiment that would allow SARS-CoV-2 antibody levels to be measured using a glucose metre.

The researchers created a unique fusion protein that contains invertase as well as a mouse antibody that binds to human immunoglobulin (IgG) antibodies. They demonstrated that the fusion protein was linked to human IgGs and was capable of producing glucose from sucrose. The scientists then created test strips containing the SARS-CoV-2 spike protein. SARS-CoV-2 antibodies bind to the spike protein when dipped in COVID-19 patient samples.

The addition of the invertase/IgG fusion protein, followed by sucrose, resulted in the formation of glucose, which could be measured using a glucose metre. They tested the test by using glucose metres to analyse a range of patient samples and discovered that the novel assay performed as well as four different ELISAs. According to the researchers, the approach may also be used to screen for SARS-CoV-2 variations and other infectious disorders.

Also Read: Over 193.53 million doses of COVID vaccination have been distributed to states and territories: Centre

Follow Medically Speaking on Instagram

According to the Union Health Ministry, India saw a significant increase in daily COVID-19 cases on Wednesday, with the country reporting 8,822 new infections in the previous 24 hours.

On Tuesday, the nation recorded 6,594 new infections, an 18% decrease from Monday’s total of 8,084 COVID-19 cases. With the addition of these new cases today, the active caseload in India has risen to 53,637, accounting for 0.12% of the entire caseload, according to the ministry.

In the last 24 hours, a total of 5,718 persons have been recovered from coronavirus infection, bringing the overall number of recoveries to 4,26,67,088. The recovery rate in India is 98.66%.

Also Read: Over 193.53 cr doses of COVID-19 vaccination distributed to states and territories: Centre

The daily positivity rate is 2%, while the weekly positivity rate is 2.35 %.

So far, 85.58 crore COVID-19 tests have been administered across the country, with 4,40,278 administered in the previous 24 hours.

Meanwhile, India’s immunisation programme has surpassed the 195.5 crore dosage threshold. This has been accomplished with 2,51,27,455 sessions.

COVID-19 immunisation for children aged 12-14 years old began on March 16, 2022. So far, more than 3.53 crore (3,53,38,654) adolescents have received the first dose of the COVID vaccination.

So far, more than 193.53 crores (1,93,53,58,865) of vaccine doses have been distributed to states/UTs, with over 13.40 crore (13,40,04,935) of balance and unutilized doses remaining.

Follow Medically Speaking on Instagram

According to a Delhi government health advisory issued on Monday, 614 new COVID-19 infections were registered in the last 24 hours.

On Sunday, the national capital reported 735 new COVID-19 infections. In the last 24 hours, there have been 495 recoveries and zero COVID-19 fatalities in the national capital, according to the health bulletin. There are now 2561 COVID-19 cases active in the city, with a 1.37 percent case fatality rate.

The total number of COVID-19 cases in the state is 1913412. While the total number of recovered patients was at 18,84,630. The total number of fatalities was 26221.

In the previous 24 hours, 8905 vaccines were administered, with 761 recipients receiving first-dose vaccinations and 1872 receiving second-dose vaccinations.

The national COVID 19 immunisation campaign began on January 16, 2021. The next phase of COVID-19 vaccine universalization began on June 21, 2021.

India saw a significant drop in COVID-19 cases, with the country reporting 6,594 new infections in the past 24 hours, or 18% less than the day before.

On Monday, the nation recorded 8,084 COVID-19 instances. This was the third day in a row that India recorded more than 8,000 cases. According to the Union Health Ministry, India’s active caseload is at 50,548 currently, representing for 0.12% of overall infections.

In the last 24 hours, a total of 4,035 persons have been recovered from coronavirus infection, bringing the overall number of recoveries to 4,26,61,370. The recovery rate in India is 98.67%.

The daily positivity rate is 2.05 percent, while the weekly positivity rate is 2.32%.

So far, 85.54 crore COVID-19 tests have been administered across the country, with 3,21,873 tests administered in the previous 24 hours.

Also Read: For second time in month, US Health Secretary tests positive for COVID-19

Meanwhile, India’s immunisation programme has achieved 195.35 crore doses under the national COVID vaccination programme. This was accomplished with 2,50,79,283 sessions.

COVID-19 immunisation for children aged 12 to 14 years old began on March 16, 2022. More than 3.52 crore (3,52,45,234) adolescents have received the first dose of the COVID vaccination thus far.

More than 193.53 crores (1,93,53,58,865) of vaccine doses have been distributed to states/UTs so far, with over 13.56 crore (13,56,98,610) of balance and unutilized doses remaining.

Follow Medically Speaking on Instagram

In the previous 24 hours, India has recorded 8582 new COVID-19 instances.

According to the Union Health Ministry, 8,582 new COVID-19 infections were detected in India in the previous 24 hours.

Also Read: Moderna COVID vaccine effective and safe for children, says USFDA

As infections rise, the country’s active COVID caseload stands at 44,513, accounting for 0.06 percent of all positive cases in India. The daily positive rate is 2.71 percent, with 3,16,179 COVID-19 tests performed in the previous 24 hours. The weekly positive rate was also reported to be 2.02%.
In the previous 24 hours, 4,435 people have recovered from COVID infection.

The ministry also stated that 3,16,179 tests were carried out in the previous 24 hours.

195.07 Bn Covid-19 vaccines administered

195.07 billion vaccine doses have been delivered across India as part of the Nationwide Vaccination Drive.

Earlier on Saturday, a total of 8,329 new Coronavirus cases were recorded in a 24-hour period, bringing the disease’s death toll to 5,24,757.

Follow Medically Speaking on Instagram